1 – 5 of 12
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes
(
- Contribution to journal › Article
- 2016
-
Mark
Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease
(
- Contribution to journal › Article
- 2015
-
Mark
A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease
(
- Contribution to journal › Article
-
Mark
Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis
(
- Contribution to journal › Article
-
Mark
Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility.
(
- Contribution to journal › Article